EDG-7 Antibodies

Santa Cruz Biotechnology features a diverse variety of EDG-7 monoclonal antibodies for research focused on understanding EDG-7 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EDG-7, also known as S1P receptor 3, is a member of the endothelial differentiation gene family and plays a crucial role in mediating cellular responses to sphingosine-1-phosphate (S1P). EDG-7 drives key physiological processes, including cell proliferation, migration, and survival, making it significant in both normal physiology and disease states. Research into EDG-7 continues to reveal important insights about its role in cancer, cardiovascular diseases, and immune responses. Scientists can leverage specific monoclonal antibodies to map EDG-7 expression patterns across different tissues and cellular compartments. Advanced research techniques supported by EDG-7 monoclonal antibodies enable detailed analysis of protein interactions and signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for EDG-7 support researchers worldwide in advancing scientific understanding of cellular signaling mechanisms.